EMN

Business Context and Reporting Period

Company: Eastman Chemical Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Overview: Eastman is a global chemical company manufacturing chemicals, plastics, and fibers. Operations are organized into three divisions: Eastman Division (specialty chemicals and plastics), Voridian Division (commodity polymers and fibers), and Developing Businesses Division. The company operates 35 manufacturing sites in 16 countries.

Key Financial Metrics (2003)

Material Changes vs. Prior Period

• Significant Impairments: The shift from profit to loss was primarily driven by $489 million in asset impairments and restructuring charges and $34 million in goodwill impairments. These charges were concentrated in the CASPI segment ($386 million) and PCI segment ($99 million) due to strategy changes and deteriorating market conditions.
• Revenue Growth: Sales increased 9% to $5.8 billion, driven by higher selling prices (offsetting raw material costs) and favorable foreign currency exchange rates (particularly the Euro), which contributed $275 million and $192 million respectively.
• Margin Compression: Gross profit margin declined to 14.0% from 14.6%. Higher raw material and energy costs negatively impacted gross profit by approximately $100 million, partially offset by price increases.
• Cash Flow: Operating cash flow decreased significantly to $244 million from $801 million in 2002. This was largely due to a $238 million contribution to U.S. defined benefit pension plans and changes in working capital.
• Asset Sales: The company recorded $33 million in other operating income from the sale of high-performance crystalline plastics assets and colorant product lines.

Guidance, Outlook, and Risks

• 2004 Outlook: Management expects profitability and operating cash flows to improve in 2004 due to restructuring actions in the CASPI segment and improved economic conditions. However, raw material and energy costs are expected to remain high.
• Cost Targets: The company targets combined Selling, General, and Administrative (S&GA) and R&D expenses to be at or below 10% of sales revenue. Capital expenditures are expected to increase but remain no more than depreciation and amortization.
• Segment Specifics:
  • CASPI: Restructuring and divestiture activities are expected to contribute approximately $50 million to operating results in 2004.
  • Developing Businesses: Operating loss is expected to be less than $45 million.
  • Polymers: Focus remains on lowering costs and growing with market demand (estimated 10% annual growth for PET polymers).
• Risks: Key risks include volatility in raw material and energy prices, foreign currency fluctuations, global economic conditions, and the ability to pass cost increases to customers. The company also faces ongoing litigation regarding sorbates price-fixing and asbestos exposure, though management does not believe these will have a material adverse effect.

Investor Verification Checklist

• Impairment Details: Verify the specific assets written down in the CASPI and PCI segments and the assumptions used for fair value calculations.
• Restructuring Progress: Monitor the execution of the CASPI segment restructuring and divestiture plans to confirm the projected $50 million benefit materializes.
• Raw Material Hedging: Review the effectiveness of hedging strategies against propane, ethane, and natural gas price volatility.
• Pension Funding: Assess the impact of the $238 million pension contribution on future liquidity and the projected $0-$40 million funding requirement for 2004.
• Debt Maturity: Confirm the successful refinancing of the $500 million debt maturing in January 2004 (subsequently retired).